Viewing Study NCT05233033


Ignite Creation Date: 2025-12-25 @ 3:01 AM
Ignite Modification Date: 2026-03-09 @ 8:18 AM
Study NCT ID: NCT05233033
Status: COMPLETED
Last Update Posted: 2024-12-10
First Post: 2022-01-18
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, PK/PD, and Clinical Activity of KT-413 in Adult Patients with Relapsed or Refractory B-cell NHL
Sponsor: Kymera Therapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module